News

Brand-drug costs rising faster than inflation


 

The cost of brand drugs increased 12.5% last year, far outpacing inflation overall, Express Scripts said in its annual Drug Trend Report.

The overall U.S. inflation rate, according to the Bureau of Labor Statistics, was only 1.7% in 2012.

From January 2008 to December 2012, the cost of an "unchanged market basket of brand drugs rose from $100 to $165.44," Express Scripts said in the report, while the Consumer Price Index, which measures a broad selection of goods and services, went from $100 to $108.80.

The cost of an unchanged selection of generic drugs did the opposite over the same 5-year period, dropping to $57.38 by the end of 2012, according to the report. All dollar values have been adjusted to 2008 dollars.

In 2012 alone, the cost of generic drugs dropped by 24.4%, following decreases of 3.7% in 2011, 14.7% in 2010, and 0.5% in 2009. The price of brand drugs rose 13.6% in 2011, 9.6% in 2010, and 9.1% in 2009, the report noted.

rfranki@frontlinemedcom.com

Recommended Reading

Health exchanges could bring unpleasant surprises
MDedge Hematology and Oncology
Battling over the budget: The Policy & Practice Podcast
MDedge Hematology and Oncology
More than 23% of uninsured didn't take medications as prescribed
MDedge Hematology and Oncology
Storify: After Boston Marathon blasts, doctors rush to help
MDedge Hematology and Oncology
Emergency physicians share lessons from Boston Marathon bombings response
MDedge Hematology and Oncology
Lawmakers take aim at ACA implementation: The Policy & Practice podcast
MDedge Hematology and Oncology
Supreme Court ponders patenting of human genes
MDedge Hematology and Oncology
ACA still not reducing ranks of uninsured
MDedge Hematology and Oncology
Know your values to achieve professional balance
MDedge Hematology and Oncology
Surgical fellowship directors: General surgery trainees arrive ill prepared
MDedge Hematology and Oncology